Jackson Creek Investment Advisors LLC Travere Therapeutics, Inc. Transaction History

Jackson Creek Investment Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$20.94 - $30.01 $882,013 - $1.26 Million	-42,121 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$23.61 - $30.6 $95,195 - $123,379	4,032 Added 10.59%	42,121 $1.09 Million
Q4 2021 Feb 01, 2022	BUY	$24.34 - $31.17 $927,086 - $1.19 Million	38,089 New	38,089 $1.18 Million
Q2 2021 Aug 03, 2021	SELL	$14.11 - $26.4 $593,396 - $1.11 Million	-42,055 Closed	0 $0
Q1 2021 May 27, 2021	SELL	$23.37 - $31.77 $29,212 - $39,712	-1,250 Reduced 2.89%	42,055 $1.05 Million
Q4 2020 Feb 03, 2021	BUY	$19.17 - $27.87 $830,156 - $1.21 Million	43,305 New	43,305 $1.18 Million

192

84.5M

776K

900K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.12B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.